Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of September 2019. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on September 10, 2019.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet and exhibit index that references a press release (Exhibit 99.1) but does not contain the financial data itself.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to administrative details and the signature block.
Important Facts for Investors to Verify
- The registrant name in the filing is Hexindai Inc., which differs from the "Akso Health Group" mentioned in the request metadata.
- Critical financial information is contained in Exhibit 99.1 (Press Release), which is referenced but not included in the provided text.
- The filing date (September 10, 2019) precedes the end of the reporting period (September 30, 2019), suggesting this may be an interim announcement rather than a full period report.